Local recurrence after radical prostatectomy and additive radiation – can PSMA-radioguided surgery prolong therapy-free survival?
Main Authors: | S. Knipper, L. Ascalone, B. Ziegler, T. Horn, W. Weber, J. Gschwend, C. Berliner, M. Eiber, M. Graefen, T. Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320334029 |
Similar Items
-
Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model
by: Pia Kraft, et al.
Published: (2020-02-01) -
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
by: Hui Wang, et al.
Published: (2021-08-01) -
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
by: Ann-Kathrin Oehus, et al.
Published: (2020-04-01) -
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
by: Else A. Aalbersberg, et al.
Published: (2020-05-01) -
Correlation between hybrid PSMA PET MRI and histopathology at radical prostatectomy
by: G. Mehawed, et al.
Published: (2020-07-01)